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The emerging multi-drug-resistant pathogens urge continuous searches for new antimicrobial agents.
This study investigated the in vitro antibacterial and antifungal activities of the stem barks of two plants,
Sorindeia madagascariensis and Albizia harveyi. Broth microdilution assay was used to determine
the minimum inhibitory concentrations (MICs) of hydroethanolic extracts of the stem barks against
selected bacteria and fungi. Both plant extracts exhibited activity against all tested microorganisms
and their minimum inhibitory concentrations (MICs) against bacteria and fungi were from 1.67 to 5.00
mg/mL and from 1.67 to 10.00 mg/mL, respectively. This study reports the antibacterial and antifungal
activities of the hydroethanolic extracts of the stem barks of both plants.Antifungal activity of A. harveyi
is being reported for the first time. We therefore suggest further investigation of bioactive compounds
from stem barks of A. harveyi and S. madagascariensis with antibacterial and antifungal activities.
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INTRODUCTION
Antimicrobial agents applications are not only in
direct treatment but also are central to several medical
procedures that require their prophylactic use (CDC,
2019). Their irrational use in human medicine and
unregulated applications in animal husbandry and crop
production continue to rise. All these have substantial
contributions to the ever-increasing problem of
antimicrobial resistance (AMR) which continues to
narrow the arsenal of antimicrobial agents (Berger et al.,
2017; CDC, 2019). AMR threatens all breakthroughs
in the medical practice, not only cause treatment
failures, but also impediment on several specialized
medical procedures that require prophylactic uses of
antimicrobial agents.
For several decades, AMR stewardship has focused
mostly on pathogenic bacterial, owing to their ubiquity
and notoriety in resistance development. However, the
pathogenic fungi that were previously considered less
problematic are now turning disastrous. Recent data
show that some pathogenic fungi, particularly Candida
albicans and Aspergillus species are increasingly getting
resistant to the most antifungals (Berger et al., 2017;
CDC, 2019). Of more concern is the recent discovery of
Candida glabrata and Candida auris that are resistant to
most of the current antifungal drugs, proving to be deadly
(CDC, 2019). The situation is alarming and together with
other measures, searching for new antimicrobial agents
is inevitable.

Preliminary searches for antimicrobial agents may entail
the exploration of nature for potential leads. Among the
natural sources, plants prove to be reliable and practical,
especially in resource-constrained parts of the world.
Their attributes of high biodiversity and long historical
uses by the traditional societies in the treatment of
ailments, make them a trustable source of bioactive
compounds (Katiyar et al., 2012; Petrovska, 2012; Rates,
2001).
In this study, the stem barks of two medicinal plants,
Sorindeia madagascariensis and Albizia harveyi were
tested for antibacterial and antifungal activities. This
was mainly induced by recent reports, whereby the leaf
extracts of both plants have been reported to exhibit
antibacterial activities (Makoye et al., 2020). Moreover,
a leaf extract of S. madagascariensis has been reported
to exhibit antifungal activity against clinically important
fungi (Mbunde et al., 2019).
Although the antifungal activity of A. harveyi has
not been reported, there are several reports on the
antifungal activity of other Albizia species, hence
raised expectation for the activity of A. harveyi (Ghaly
et al., 2010; Maroyi, 2018; Samoylenko et al., 2009;
Thippeswamy et al., 2014). We therefore studied the
antibacterial and antifungal activities of the stem barks
of S. madagascariensis and A. harveyi as part of our
continued investigations on the two species against
selected pathogenic bacteria and fungi (Makoye et al.,
2020; Mbunde et al., 2019).
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METHODS

Committee for Antimicrobial Susceptibility Testing
(EUCAST) guidelines of 2003 (European Committee
for Antimicrobial Susceptibility Testing, 2003) was used
to screen and quantify the antibacterial and antifungal
activities of the extracts. The minimum inhibitory
concentrations (MICs) of the extracts against selected
standard and clinical isolates of bacteria and fungi were
measured.

Plant Identification and Collection
The stem barks of S. madagascariensis and A. harveyi
were collected from Chalinze district of Tanzania.
Specimens of their leaves were as well collected and used
for confirmation of identity of the plants by a botanist
at the Institute of Traditional Medicines, Muhimbili
University of Health and Allied Sciences, Tanzania. The
collected stem barks were size-reduced and dried under
shade, after which they were separately pulverized into
coarse powders using a milling machine (locally made).

Preparation of extract stock solutions and test standards
The extracts stock solutions were prepared by dissolving
200 mg of each extract in separate 8 mL of Muller Hinton
broth (Oxoid, UK) (MHB) and Sabouraud dextrose broth
(Oxoid, UK) (SDB) for antibacterial and antifungal
testing respectively. In each mixture, 2 mL of dimethyl
sulfoxide (DMSO) (Fisher Scientific, UK) were added
to aid dissolution of the extracts. This constituted 20
mg/mL stock solutions of the extracts. Ciprofloxacin
(Sigma-Aldrich, Germany) and fluconazole (Lincoln
Pharmaceuticals Ltd, India) were used as positive
controls for bacteria and fungi, respectively. Their
stock solutions were prepared by dissolving 13.3 mg of
ciprofloxacin and 2 g of fluconazole in 100 mL of MHB
and SDB respectively. This resulted into stock solutions
of 133 µg/mL and 20 mg/mL for ciprofloxacin and
fluconazole respectively.

Extraction
The obtained stem bark powders were thoroughly
extracted with 80% ethanol by cold maceration for four
days in closed containers. This process was followed
with twelve hourly agitations. The obtained extracts
were filtered using Whatman filter paper no. 1 and
concentrated in vacuo (Buchi®, Switzerland) at 55℃.
The concentrates were then freeze-dried, kept in airtight
containers and stored at 4℃.
Phytochemical Evaluation
Standard qualitative methods were adopted from
literature (Rao et al., 2016; Shah & Seth, 2013) and used
to detect the presence of phytochemical classes include:
tannins, saponins, alkaloids, phenols, phytosterols,
glycosides, terpenoids, triterpenoids and flavonoids
present in the hydroethanolic extracts of the stem barks
of both plants.

Test microorganisms and media
Selection of the test organisms was guided by their
medical importance (CDC, 2019; WHO, 2017) and
availability. Tested bacteria included the standard
Escherichia coli ATCC 25922, Klebsiella pneumoniae
ATCC700603, Staphylococcus aureus ATCC 25923,
and Pseudomonas aeruginosa ATCC 27853. Clinical

Antimicrobial Activities Study
Broth microdilution assay as described in the European

Table 1. Phytochemical screening results for the stem barks of A. harveyi and S. madagascariensis
Phytochemical
Tested

Name of the Test

A. harveyi stem bark

S. madagascariensis stem bark

Tannins
Saponins
Alkaloids

Ferric chloride test
Foam test
Mayer’s test
Wagner’s test
Ferric chloride test
Sulphuric acid test
Salkowski’s test
Liebermann Burchard test
Liebermann’s test
Salkowski’s test
Liebermann Burchard test
Lead acetate test

+
+
+
+
+
+
+
+
+
-

+
+
+
+
+
+
-

Phenols
Phytosterols
Glycosides
Terpenoids
Triterpenoids
Flavonoids

+ the tested phytochemical was detected
- the tested phytochemical was not detected
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isolates of the same bacteria and a methicillin-resistant
Staphylococcus aureus (MRSA) were included as well.
Tested fungi included the standards Candida albicans
ATCC 13803, Cryptococcus neoformans ATCC 90112,
and Aspergillus niger AZN 8240, as well as the clinical
isolates of Candida albicans and Aspergillus niger.
Before activity testing, the test bacteria and fungi were
reactivated by sub-culturing at 37 oC for 24 and 48
hours on nutrient agar (Techno Pharmchem, India) and
Sabouraud Dextrose Broth (SDB), respectively. Testing
of the antibacterial and antifungal activities of the
extracts was subsequently performed in Mueller Hinton
Broth (MHB) and SDB, respectively.
Determination of Minimum Inhibitory Concentrations
(MICs)
MICs determinations were carried out in 96-wells
microtiter plates (Becton Dickinson Labware, USA).
One plate was dedicated for each organism and the
respective extracts and positive controls were each tested
in three adjacent lanes (columns) of the plates. Initially,
all wells of the microtiter plates were added with 100
µL of broth whereby MHB and SDB were added in the
plates dedicated for bacteria and fungi, respectively.
Furthermore, 100 µL of the prepared solutions for
extracts and positive controls were added into the firstrow of wells in triplicate.. The added solutions were
thoroughly mixed with the previously added broth. From
those wells, 100 µL of the resulting mixtures were drawn
and added to the respective wells in the next row and
mixed with the previously added broth again.
This was repeated serially down the plates to the last row
whereby the last drawn of 100 µL were discarded. This
resulted 2-fold dilutions of both the extracts and positive
controls down the columns of the wells. Following that,
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each well was inoculated with 100 µL of the respective
microbial suspensions at 1 x 106 cfu/mL which were
previously prepared by mixing 0.1 mL of 0.5 McFarlandequivalents (approximately 1 x 108 cfu/mL) of bacterial
and fungal suspensions with 9.9 mL of MHB and SDB
respectively (European Committee for Antimicrobial
Susceptibility Testing, 2003).
The inoculated plates were incubated at 37ºC for 24and 48- hours for bacteria and fungi. respectively.
Following incubation periods, 30µl of a 0.2 mg/mL
iodonitrotetrazolium chloride stain (Sigma-Aldrich)
(INT) were added into the wells, and the plates were
re-incubated for 30 minutes. Growth inhibition was
inferred when no colour changes were observed,
whereas formation of purple or pink colour indicated
non-inhibition of the growth of the test micro-organisms.
The lowest concentrations revealing growth inhibition
were regarded as the MICs. The whole experiment was
repeated three times in different days and the results
were presented as mean values of the MICs with their
standard deviations.
Statistical analysis
Mean MIC values and their standard deviations were
analyzed using Microsoft excel 2013 software. GraphPad
Prism 8 software was used to analyze one-way analysis
of variance (ANOVA) and subsequently the Tuckey’s
honest significant tests of the observed differences in
MICs among the extracts and positive controls. The
results were graphically elucidated using the GraphPad
Prism 8 software as well.
RESULTS
Phytochemical Evaluation
Phytochemical groups including tannins, saponins,

Table 2. Minimum inhibitory concentrations of the stem barks of A. harveyi and S. madagascariensis
against bacteria
Test Bacteria

A. harveyi stem bark
(mg/mL)

S. madagascariensis
stem bark (mg/mL)

Ciprofloxacin (mg/mL)

E. coli ATCC 25922
K. pneumoniae ATCC700603
P. aeruginosa ATCC 27853
S. aureus ATCC 25923
Clinical isolate E. coli
Clinical isolate K. pneumoniae
Clinical isolate P. aeruginosa
Clinical isolate S. aureus
Methicillin Resistant S. aureus

1.67 ± 0.72
3.33 ± 1.44
2.50 ± 0.00
1.67 ± 0.72
1.67 ± 0.72
1.67 ± 0.72
5.00 ± 0.00
1.67 ± 0.72
1.67 ± 0.72

3.33± 1.44
2.50 ± 0.00
5.00 ± 0.00
1.67 ± 0.72
3.33 ± 1.44
3.33 ± 1.44
3.33 ± 1.44
1.67 ± 0.72
1.67 ± 0.72

0.002 ± 0.00
>0.0665
0.041 ± 0.03
0.078 ± 0.05
0.015 ± 0.00
0.005 ± 0.00
0.052 ± 0.05
>0.0665
>0.0665

Data presented in mean±SD
> means no inhibition was observed up to the well with the highest concentration
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Figure 1. The overall mean values of minimum
inhibitory concentrations of the stem barks of A. harveyi
and S. madagascariensis against selected bacteria. Data
in mean ± SD, ns = the observed difference in activity is
statistically non-significant, p > 0.05, ***the observed
difference is statistically significant with p-value =
0.001 and ****the observed difference is statistically
significant with p-value = 0.0002
phenols, phytosterols, glycosides and terpenoids
were detected in the extracts of both A. harveyi and S.
madagascariensis, as described in Table 1. Triterpenoids
were further detected in A. harveyi but not in S.
madagascariensis extract. In both extracts, alkaloids and
flavonoids were not detected.
Antibacterial Activity
The extracts of both plants exhibited activity against all
tested bacteria at MICs ranging from 1.67 to 5.00 mg/
mL. The highest observed activity (1.67 ± 0.72 mg/mL)
was exhibited by both extract against S. aureus ATCC
25923, a clinical isolate of S. aureus and the MRSA. A.
harveyi extract further displayed this activity against E.
coli ATCC 25922 and the clinical isolates of E. coli and
K. pneumoniae, as described in Table 2. The rest of the
organisms were all susceptible to both extracts, however
starting at MICs of 2.5 mg/mL.
Upon one-way analysis of variance, with subsequent
Tukey’s multiple comparisons test at 95% confidence
level, the antibacterial activities of the two extracts
were found to be statistically similar (p = 0.483).
However, the antibacterial activities of the two extracts
were found to be far inferior to that of the control drug,
ciprofloxacin justified by p-values of 0.001 and 0.0002
for A. harveyi and S. madagascariensis respectively, as
depicted in Figure 1.
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Antifungal Activity
The extracts inhibited all tested fungi at concentration
ranges between 1.67 to 6.67 mg/mL and 1.67 to 10.00 mg/
mL for A. harveyi and S. madagascariensis, respectively.
They both exhibited the highest activity (1.67 ± 0.72
mg/mL) against a clinical isolate of C. albicans. This
MIC was further displayed by A. harveyi against C.
albicans ATCC 13803 and C. neoformans ATCC 90112.
Aspergillus niger AZN 8240 and its clinical isolate were
the least susceptible to the extracts being inhibited at
MICs ranging from 5.00 to 10.00 mg/mL. Moreover,
the tested fungi were all susceptible to the control drug,
fluconazole and were inhibited at MICs ranging from
0.66 to 10.00 mg/mL, as shown in Table 3.
One-way analysis of variance indicated the antifungal
activities of the two plant extracts to be similar to that
of the control drug, fluconazole (p = 0.165), as depicted
in Figure 2.
DISCUSSION
The phytochemical profile of an extract is a key
determinant of its bioactivity. Several phytoconstituents
have been characterized from nature and their bioactivities
are well known today. Tannins, phenolics and saponins,
as well as alkaloids, terpenes, and flavonoids for
example, are well known for their antibacterial and
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Table 3. Minimum inhibitory concentrations of the stem barks of A. harveyi and S.
madagascariensis against fungi
Organism
C. albicans ATCC 13803
A. niger AZN 8240
C. neoformans ATCC 90112
Clinical isolate C. albicans
Clinical isolate A. niger

A. harveyi stem bark
(mg/mL)
1. 67 ± 0.72
6.67 ± 2.89
1.67 ± 0.72
1.67 ± 0.72
5.00 ± 0.00

S. madagascariensis
stem bark (mg/mL)
3.33 ± 1.44
10.00 ± 0.00
6.67 ± 2.89
1.67 ± 0.72
6.67 ± 2.89

Fluconazole
(mg/mL)
1.67 ± 0.72
3.33 ± 1.44
0.63 ± 0.00
3.33 ± 1.44
6.67 ± 2.89

Data presented in mean±SD

Figure 1. The overall mean values of minimum inhibitory
concentrations of the stem barks of A. harveyi and S.
madagascariensis against selected fungi. Data in mean ± SD,
ns = the observed difference in activity is statistically nonsignificant, p > 0.05
antifungal activities, among other bioactivities (Arabski
et al., 2012; Bahri-Sahloul et al., 2014; Makgatho et al.,
2018; Trdá et al., 2019; C. R. Yang et al., 2006; L. Yang
et al., 2018; Zacchino et al., 2017; Zhu et al., 2019).
With exception to alkaloids and flavonoids, we report
detection of tannins, saponins and phenolics, as well
as phytosterols, glycosides, and terpenoids in the
hydroethanolic stembark extract of A. harveyi. Nondetection of alkaloids in this study is congruent to the
published findings on a hydroethanolic leaf extract of
A. harveyi. However, non-detection of flavonoids in the
stem bark extract of the plant, differs from the findings
on the same leaf extract (Makoye et al., 2020). This
discrepancy can be due to the natural distribution of
flavonoids, more to the aerial than the lower parts of

plants (Lwashina, 2000), as well as, the intraspecific
variations of phytochemical composition resulting from
geo-climatic conditions (Omara et al., 2021).
Moreover, it is notable that the highest observed
antibacterial activity for the stembark extract (1.67 ±
0.72 mg/ml) of A. harveyi, is very slightly lower than
the highest activity reported for its leaf extract (1.28 ±
0.44 mg/ml) (Makoye et al., 2020). Considering this
resemblance of the activities, and the non-detection of
flavonoids in the stembark extract, it can be proposed
that the previously detected flavonoids in the leaf extract
had small or no contribution on the antibacterial activity
of the leaf extract and the other phytochemicals could be
responsible for the activity.
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Interestingly, the observed antifungal activity for A.
harveyi in this study appears to be novel. Together with
the other phytochemicals, the detected saponins, terpenes
and tannins are probably responsible for this activity,
since the antifungal activities for these phytochemical
classes are established (Monteiro & Alves dos Santos,
2019). Moreover, the newly observed antifungal activity
for the plant is well supported by existing reports on
the antifungal activities of other Albizia species (Feyera
Fufa et al., 2018; Thippeswamy et al., 2014, 2015).
Furthermore, A. harveyi displayed higher antifungal
activity than the control drug, fluconazole against three
organisms namely, C. albicans ATCC 13803 (1.67 ±
0.72 mg/mL) and the clinical isolates of C. albicans
(1.67 ± 0.72 mg/mL) and A. niger (5.00 ± 0.00 mg/mL).
All these fungi cause mild to severe infections especially
in immunologically challenged individuals (Brown
et al., 2012; Perlroth et al., 2007; Pfaller et al., 2006;
Richardson, 2005). This means if further explored, the
plant may give potential leads for effective antifungal
agents.
With exception to alkaloids, phytosterols, triterpenoids
and flavonoids, the rest of the tested phytochemicals
were detected in the 80% hydroethanolic extract of
the stem bark of S. madagascariensis. With addition to
flavonoids, a comparable pattern, with more intense (++)
detections, has been reported for the leaf extract of S.
madagascariensis (Makoye et al., 2020). Comparing the
phytochemical detection color intensities in this study
(+), with the previous findings (++), it can be judged
that the stembark of the plant is phytochemically weaker
than its leaf.
The less phytochemical of the stembark of S.
madagascariensis as compared to its leaf, may explain
that the highest antibacterial activity observed for the
stembark extract in this study (1.67 ± 0.72 mg/mL), is
8-fold less than the reported activity for the leaf extract
of the plant (0.192 ± 0.00 mg/mL) (Makoye et al., 2020).
Likewise, its highest antifungal activity observed in this
study (1.67 ± 0.72 mg/mL) is about 2-fold less than
what is reported of its leaf extract (0.625±0.00 mg/mL)
(Mbunde et al., 2019).
Moreover, the observed susceptibility trends of the
tested bacteria and fungi to the stem bark extract of S.
madagascariensis are lower than the ones depicted in the
studies on its leaf extracts (Makoye et al., 2020; Mbunde
et al., 2019). Therefore, these findings not only reveal
the activities of the stem bark of S. madagascariensis,
but also inform that, its stem bark may offer weaker
potency compared to its leaf in the quest for antibacterial
and antifungal chemical leads.
E-ISSN 2477-0612
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Furthermore, the antibacterial activity of ciprofloxacin
(positive control) was up to 1000 times the activities
of both plant extracts, against the respective bacteria.
This is a usual occurrence and further processing of the
extracts, particularly fractionation may significantly
improve their activities. In addition to that, it is notable
that the clinical isolates of C. albicans and A. niger, were
generally more susceptible to the plant extracts, than
their standard counterparts. This is quite unusual and
can be ascribed to several uncontrolled experimental
factors. Mutation of the standard/clinical isolated fungi
may have contributed to these findings.
CONCLUSION
The 80% hydroethanolic extracts of the stem barks of A.
harveyi and S. madagascariensis exhibited antibacterial
and antifungal activities. The antifungal activity of A.
harveyi is hereby reported for the first time. Drawing
from these findings, we suggest that the stem bark and
other organs of both plants be further investigated for
lead compounds with antibacterial and/or antifungal
activities.
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